Oruka Therapeutics (ORKA) Q4 2024 Earnings

13NovConfirmed
Q3 2024
Q4 2024
-1.46
-1.11
-0.75
-0.4

Details

Expected EPS
-0.4019
Actual EPS
-1.46
Surprise EPS
-1.06
Surprise Percent
+263.27%

Description

Oruka Therapeutics (ORKA) has reported earnings of -1.46 per share for Q4 2024.

0 Comments

Share your thoughts